-
-
-
-
-
-
-
BioVie Inc. (BIVI) Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients
-
-
-
-
-
-
-
Rezolute Inc. (RZLT) Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402
-
-
-
-
-
-
-
Palisade Bio Inc. (PALI) Reports PALI-2108 Demonstrated Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) Announces Bristol Myers Squibb (BMY) Received Updated Action Date from FDA for Subcutaneous Nivolumab Co-Formulated with ENHANZE
-
-
-
-
-
-
-
Sonnet BioTherapeutics (SONN) Reports Updated Clinical Data for SON-1010
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Reports EU Commission Returns Translarna Opinion to CHMP For Re-evaluation
-
-
-
-
-
-
-
Bond buying on bets for Fed cutting cycle 'misplaced,' MRB Partners says
-
67,133 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.